Geneva Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.39M | Sell |
7,951
-621
| -7% | -$108K | 0.02% | 297 |
|
|
2017
Q1 | $1.32M | Sell |
8,572
-719
| -8% | -$110K | 0.02% | 297 |
|
|
2016
Q4 | $1.31M | Sell |
9,291
-1,244
| -12% | -$176K | 0.03% | 275 |
|
|
2016
Q3 | $1.68M | Sell |
10,535
-367
| -3% | -$58.4K | 0.03% | 226 |
|
|
2016
Q2 | $1.61M | Sell |
10,902
-11
| -0.1% | -$1.63K | 0.03% | 225 |
|
|
2016
Q1 | $1.55M | Sell |
10,913
-20
| -0.2% | -$2.83K | 0.03% | 225 |
|
|
2015
Q4 | $1.55M | Buy |
10,933
+5,447
| +99% | +$773K | 0.03% | 234 |
|
|
2015
Q3 | $671K | Buy |
5,486
+3,759
| +218% | +$460K | 0.01% | 345 |
|
|
2015
Q2 | $224K | Buy |
+1,727
| New | +$224K | ﹤0.01% | 582 |
|
|
2014
Q4 | – | Sell |
-2,306
| Closed | -$281K | – | 739 |
|
|
2014
Q3 | $281K | Sell |
2,306
-73
| -3% | -$8.9K | 0.01% | 528 |
|
|
2014
Q2 | $281K | Sell |
2,379
-200
| -8% | -$23.6K | 0.01% | 530 |
|
|
2014
Q1 | $310K | Buy |
+2,579
| New | +$310K | 0.01% | 471 |
|
|
2013
Q4 | – | Sell |
-10,085
| Closed | -$929K | – | 592 |
|
|
2013
Q3 | $929K | Buy |
10,085
+2,285
| +29% | +$210K | 0.02% | 262 |
|
|
2013
Q2 | $660K | Buy |
+7,800
| New | +$660K | 0.02% | 259 |
|